Navigation Links
Andre Marion Joins Microchip Biotechnologies' Board of Directors
Date:5/7/2009

DUBLIN, Calif., May 7 /PRNewswire/ -- Microchip Biotechnologies, a private company developing the Apollo next-generation fluidics platform for life sciences, announced today that Andre F. Marion has accepted a board position to its Board of Directors, effective immediately. Mr. Marion was former CEO of Applied Biosystems and today serves on the boards of several venture capital backed companies.

"Andre Marion brings an immense depth of global commercial and operational experience in the life science tools market to Microchip Biotechnologies' Board of Directors. His leadership of Applied Biosystems and experience on other Boards will greatly assist the stewardship of our company," said Dr. Stevan Jovanovich, President and CEO of Microchip Biotechnologies.

"I believe that the simplicity, flexibility and potential for low cost manufacturing offered by Microchip Biotechnologies' Apollo platform are particularly well suited for the design of integrated systems that can accelerate the collection, preparation and analysis of biological samples," said Mr. Marion. "A wide variety of applications in life science research, diagnostics, and environmental fields, that require robustness and reliability, are obvious candidates for the platform."

Andre F. Marion was a co-founder of Applied Biosystems; Applied Biosystems was acquired by Invitrogen in 2008 to form Life Technologies. At Applied Biosystems Mr. Marion held a series of pivotal positions. He initially held the post of Vice President of Engineering in 1981 and became Chief Operating Officer in 1983. In 1986 Mr. Marion was promoted to President and Chief Executive Officer of Applied Biosystems and also held the position of Chairman of the Board from 1987 until 1993 when Applied Biosystems merged with Perkin Elmer. Andre F. Marion retired from Perkin Elmer Corporation as President of the Applied Biosystems Division in 1993. Prior to founding Applied Biosystems, he held various Research and Development managerial positions at Hewlett-Packard.

As a native of France, Mr. Andre F. Marion holds an engineering degree from the French Ecole Nationale Superieures d'Ingenieurs Arts et Metiers in both mechanical and electronic engineering.

About Microchip Biotechnologies

Microchip Biotechnologies, Inc., (MBI), is a privately-held company located in Dublin, California. The company is developing the Apollo next-generation fluidics platform for life sciences, applied sciences, and diagnostics markets. The Apollo platform integrates advanced microfluidic sample preparation, and analytical capabilities, to produce sample-to-answer performance for DNA sequencing, biodefense, DNA-based forensics and human identity (HID), and molecular diagnostics applications. The platform incorporates MBI's proprietary BeadStorm(TM) bead-based sample preparation devices and 'Microscale On-Chip Valve' (MOVe(TM)) valves, pumps, and routers on microchips. More details about MBI, its technologies and products can be found at: www.microchipbiotech.com


'/>"/>
SOURCE Microchip Biotechnologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Veridiam Appoints Andrew Gale as Chief Executive Officer
2. Andrew Chisholm Appointed Vice President, Sales and Corporate Accounts at Accumetrics
3. Algeta Appoints Andrew Kay as President and Chief Executive Officer
4. Cyntellect Appoints Former BD Biosciences Executive Andre Lubarsky as Director of Sales - North America
5. [video] Ronald Andrews, CEO of Clarient, Inc. Discusses Agreement With University of Pennsylvania School of Medicine on WallSt.nets 3-Minute Press Show
6. Warner Chilcott Reports the Death of Its Director James Andress
7. 5AM Ventures Announces Expansion of Investment Team: Names Richard Ulevitch Venture Partner; Promotes Kevin Forrest and Andrew McMillan to Principal
8. Clarient CEO Ron Andrews to Participate in OneMedPlace Emerging Healthcare Technologies Finance Forum
9. MacAndrews & Forbes Names Barry F. Schwartz as Executive Vice Chairman
10. Genstructs Andrea Matthews Selected for Mass High Techs People to Watch Under 30
11. Vical Names Andrew de Guttadauro Vice President, Corporate Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... China , Feb. 4, 2016 Beike ... and various medical institutions attended a ceremony in late ... integrative, personalized cell therapy in 2016. ... "Shenzhen Clinical Translation Platform for Personalized Cell Therapy" was ... Regional Cell Production Center, both subsidiaries of Beike Biotechnology ...
(Date:2/4/2016)... -- --> --> Q ... to provide the following update on recent corporate developments. ... 3 months we have significantly increased our cash position through ... a result, we have positioned ourselves to execute on the ... expect that development to continue on schedule. ...
(Date:2/4/2016)... Sinovac Biotech Ltd. ("Sinovac" or the "Company") (NASDAQ: ... China , today announced that the ... February 4, 2016 a preliminary non-binding proposal letter, dated ... V-Ming ( Shanghai ) Investment Holdings Co., ... Shenzhen ) Fund Management Co., Ltd., Beijing ...
(Date:2/4/2016)... ... February 04, 2016 , ... Many of the engineers at FireflySci, ... What sets them apart from other cuvette manufacturers is their supercharged customer service ... On top of this steady flow of inside information, they have recently revamped ...
Breaking Biology Technology:
(Date:2/1/2016)... YORK , Feb. 1, 2016  Today, the ... Association (AHA) announced plans to develop a first of ... computing power of IBM Watson. In the first application ... AHA, IBM (NYSE: IBM ), and Welltok will ... and health assessments with cognitive analytics, delivered on Welltok,s ...
(Date:1/25/2016)... , Jan. 25, 2016  Glencoe Software, the ... pharma and publication industries, will provide the data management ... Centre (NPSC). ... Phenotypic analysis measures ... whole organisms, allowing comparisons between states such as health ...
(Date:1/20/2016)... Jan. 20, 2016   MedNet Solutions , an ... spectrum of clinical research, is pleased to announce the ... achievements are the result of the company,s laser focus ... eClinical , it,s comprehensive, easy-to-use and highly affordable ... --> Key MedNet growth achievements in 2015 include: ...
Breaking Biology News(10 mins):